| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 07:33:59 UTC |
|---|
| Update Date | 2021-09-26 23:02:03 UTC |
|---|
| HMDB ID | HMDB0250534 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Crenolanib |
|---|
| Description | Crenolanib belongs to the class of organic compounds known as aminoquinolines and derivatives. These are organic compounds containing an amino group attached to a quinoline ring system. Furthermore, PDGFB translocation to the COL1A1 gene locus has been identified to be responsible for dermatofibrosarcoma protuberans (DFSP). Crenolanib is a very strong basic compound (based on its pKa). Evaluation of the antitumor activity of crenolanib in a genetically engineered BSG DIPG mouse model showed that it is highly selective for PDGFRβ with an IC50 of 10 nM when measured by BrdU assay and 1.25 uM by MTT assay. Human bone marrow progenitor cell growth assays showed that crenolanib has modest effects on GM-CSF and BFUE driven colony formation at the IC50 concentration of 20 nM.Phase I single-agent and Phase Ib combination studies have investigated the clinical pharmacology of crenolanib in patients with cancer. MTT assay measurements of crenolanib cytotoxicity evaluated in the FLT3-ITD expressing cell lines Molm14 and MV411, showed that crenolanib is toxic at IC50 concentrations of 7 nM and 8 nM, respectively. This compound has been identified in human blood as reported by (PMID: 31557052 ). Crenolanib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Crenolanib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC1(COC2=CC=C3N(C=NC3=C2)C2=CC=C3C=CC=C(N4CCC(N)CC4)C3=N2)COC1 InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| CP-868596CRENOLANIB | ChEMBL |
|
|---|
| Chemical Formula | C26H29N5O2 |
|---|
| Average Molecular Weight | 443.551 |
|---|
| Monoisotopic Molecular Weight | 443.232125194 |
|---|
| IUPAC Name | 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1H-1,3-benzodiazol-1-yl}quinolin-8-yl)piperidin-4-amine |
|---|
| Traditional Name | crenolanib |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1(COC2=CC=C3N(C=NC3=C2)C2=CC=C3C=CC=C(N4CCC(N)CC4)C3=N2)COC1 |
|---|
| InChI Identifier | InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3 |
|---|
| InChI Key | DYNHJHQFHQTFTP-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aminoquinolines and derivatives. These are organic compounds containing an amino group attached to a quinoline ring system. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Quinolines and derivatives |
|---|
| Sub Class | Aminoquinolines and derivatives |
|---|
| Direct Parent | Aminoquinolines and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminoquinoline
- Benzimidazole
- Dialkylarylamine
- Tertiary aliphatic/aromatic amine
- Phenol ether
- Alkyl aryl ether
- 4-aminopiperidine
- Benzenoid
- Pyridine
- N-substituted imidazole
- Piperidine
- Heteroaromatic compound
- Azole
- Imidazole
- Tertiary amine
- Oxetane
- Ether
- Dialkyl ether
- Azacycle
- Oxacycle
- Organonitrogen compound
- Primary amine
- Primary aliphatic amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Organooxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 11.4031 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.29 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1863.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 197.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 214.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 187.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 126.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 467.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 384.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 483.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 924.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 346.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 934.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 290.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 332.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 347.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 485.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Crenolanib,1TMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N[Si](C)(C)C)CC4)C3=N2)COC1 | 4303.6 | Semi standard non polar | 33892256 | | Crenolanib,1TMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N[Si](C)(C)C)CC4)C3=N2)COC1 | 4102.7 | Standard non polar | 33892256 | | Crenolanib,1TMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N[Si](C)(C)C)CC4)C3=N2)COC1 | 5459.5 | Standard polar | 33892256 | | Crenolanib,2TMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N([Si](C)(C)C)[Si](C)(C)C)CC4)C3=N2)COC1 | 4283.2 | Semi standard non polar | 33892256 | | Crenolanib,2TMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N([Si](C)(C)C)[Si](C)(C)C)CC4)C3=N2)COC1 | 4213.8 | Standard non polar | 33892256 | | Crenolanib,2TMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N([Si](C)(C)C)[Si](C)(C)C)CC4)C3=N2)COC1 | 5320.3 | Standard polar | 33892256 | | Crenolanib,1TBDMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N[Si](C)(C)C(C)(C)C)CC4)C3=N2)COC1 | 4547.3 | Semi standard non polar | 33892256 | | Crenolanib,1TBDMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N[Si](C)(C)C(C)(C)C)CC4)C3=N2)COC1 | 4315.2 | Standard non polar | 33892256 | | Crenolanib,1TBDMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N[Si](C)(C)C(C)(C)C)CC4)C3=N2)COC1 | 5437.5 | Standard polar | 33892256 | | Crenolanib,2TBDMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC4)C3=N2)COC1 | 4666.7 | Semi standard non polar | 33892256 | | Crenolanib,2TBDMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC4)C3=N2)COC1 | 4607.7 | Standard non polar | 33892256 | | Crenolanib,2TBDMS,isomer #1 | CC1(COC2=CC=C3C(=C2)N=CN3C2=CC=C3C=CC=C(N4CCC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC4)C3=N2)COC1 | 5232.4 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Crenolanib GC-MS (Non-derivatized) - 70eV, Positive | splash10-02vi-3126900000-b50818b4b52397a74c87 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Crenolanib GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 10V, Positive-QTOF | splash10-002f-0000900000-329a9824d37d49323ada | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 20V, Positive-QTOF | splash10-00mo-0143900000-9fb6ff3a83b271b12de6 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 40V, Positive-QTOF | splash10-014i-7976000000-6131fb8f0d144f1b0248 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 10V, Negative-QTOF | splash10-0006-1000900000-280fdf7531a2c9be5a8b | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 20V, Negative-QTOF | splash10-00kf-4252900000-f8b8f3d59bede5ca0750 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 40V, Negative-QTOF | splash10-00sr-4944000000-6eb07e180a53b14bbf84 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 10V, Positive-QTOF | splash10-0006-0000900000-884097a485a339237485 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 20V, Positive-QTOF | splash10-0ikc-0002900000-7b5b9d93fbce58f96ab1 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 40V, Positive-QTOF | splash10-0a4i-9125500000-4d760e8506f572590566 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 10V, Negative-QTOF | splash10-0006-0000900000-589795cbd2642e93195f | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 20V, Negative-QTOF | splash10-0006-0002900000-e73079defc1a969c0148 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Crenolanib 40V, Negative-QTOF | splash10-01t9-0009500000-cb6b3789f1afa069e726 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|